XML 18 R39.htm IDEA: XBRL DOCUMENT v2.4.1.9
Acquisition and Stockholders' Equity (Deficit) (Details 8) (ContraVir Subsidiary, Loan and Security Agreement, USD $)
0 Months Ended
Mar. 27, 2014
Jan. 09, 2014
Oct. 18, 2013
Aug. 29, 2013
Jun. 05, 2013
Nov. 18, 2013
Jun. 05, 2013
ContraVir Subsidiary | Loan and Security Agreement
             
Acquisition and Stockholders' Equity (Deficit)              
Maximum amount entity agreed to lend         $ 500,000sgyp_MaximumLendingToSubsidiary
/ us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis
= us-gaap_LoansReceivableMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= sgyp_ContraVirPharmaceuticalsIncMember
$ 1,000,000sgyp_MaximumLendingToSubsidiary
/ us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis
= us-gaap_LoansReceivableMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= sgyp_ContraVirPharmaceuticalsIncMember
$ 500,000sgyp_MaximumLendingToSubsidiary
/ us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis
= us-gaap_LoansReceivableMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= sgyp_ContraVirPharmaceuticalsIncMember
Amount of advance to subsidiary   100,000sgyp_PaymentsForAdvanceToSubsidiary
/ us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis
= us-gaap_LoansReceivableMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= sgyp_ContraVirPharmaceuticalsIncMember
150,000sgyp_PaymentsForAdvanceToSubsidiary
/ us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis
= us-gaap_LoansReceivableMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= sgyp_ContraVirPharmaceuticalsIncMember
100,000sgyp_PaymentsForAdvanceToSubsidiary
/ us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis
= us-gaap_LoansReceivableMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= sgyp_ContraVirPharmaceuticalsIncMember
100,000sgyp_PaymentsForAdvanceToSubsidiary
/ us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis
= us-gaap_LoansReceivableMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= sgyp_ContraVirPharmaceuticalsIncMember
   
Interest rate (as a percent)         6.00%sgyp_LoanReceivableInterestRateStatedPercentage
/ us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis
= us-gaap_LoansReceivableMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= sgyp_ContraVirPharmaceuticalsIncMember
  6.00%sgyp_LoanReceivableInterestRateStatedPercentage
/ us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis
= us-gaap_LoansReceivableMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= sgyp_ContraVirPharmaceuticalsIncMember
Repayment of advance by ContraVir $ 461,236sgyp_ProceedsFromCollectionOfAdvanceToSubsidiary
/ us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis
= us-gaap_LoansReceivableMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= sgyp_ContraVirPharmaceuticalsIncMember